These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11785099)

  • 1. [Peroxidase activity in human uterine tissue: connection with clinico-morphological features of endometrial cancer].
    Vasil'ev DA; Kovalenko IG; Kvachevskaia IuO; Bakhidze EV; Chepik OF; Bershteĭn LM
    Vopr Onkol; 2001; 47(5):575-9. PubMed ID: 11785099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione peroxidase activity in endometrium: effects of sex hormones and cancer.
    Ohwada M; Suzuki M; Sato I; Tsukamoto H; Watanabe K
    Gynecol Oncol; 1996 Feb; 60(2):277-82. PubMed ID: 8631551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer].
    Bersteĭn LM; Chernobrovkina AE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Maksimov SIa; Chepik OF; Gershfel'd ED
    Vopr Onkol; 2003; 49(1):55-9. PubMed ID: 12715371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of peroxidase and granulocytes in the human uterus.
    Press MF; King WJ
    Lab Invest; 1986 Feb; 54(2):188-203. PubMed ID: 3945052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on specific markers of hormone-dependence in endometrial carcinoma : estradiol receptors and uterine peroxidase (author's transl)].
    Morikawa S; Sekiya S; Takamizawa H
    Acta Obstet Gynaecol Jpn; 1981 Mar; 33(3):339-43. PubMed ID: 7211223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase and telomere length in normal and malignant human endometrium as prognostic markers.
    Menon MM; Simha MR
    Indian J Pathol Microbiol; 2003 Jul; 46(3):394-8. PubMed ID: 15025282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
    Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
    Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial effect of human endometrial peroxidase on Escherichia coli and Staphylococcus aureus].
    Iwasaku K; Yasuda J; Hatsuda K; Yamamoto T; Okada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):99-105. PubMed ID: 3546536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer.
    Shia J; Black D; Hummer AJ; Boyd J; Soslow RA
    Hum Pathol; 2008 Jan; 39(1):116-25. PubMed ID: 17949789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
    Pilka R; Norata GD; Domanski H; Andersson C; Hansson S; Eriksson P; Casslén B
    Gynecol Oncol; 2004 Sep; 94(3):661-70. PubMed ID: 15350356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
    Mazurek A; Kuc P; Terlikowski S; Laudanski T
    Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the serine protease hepsin and clinical outcome of human endometrial cancer.
    Matsuo T; Nakamura K; Takamoto N; Kodama J; Hongo A; Abrzua F; Nasu Y; Kumon H; Hiramatsu Y
    Anticancer Res; 2008; 28(1A):159-64. PubMed ID: 18383840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100 as an immunohistochemically-detected marker with prognostic significance in endometrial carcinoma.
    Honig A; Schaller N; Dietl J; Backe J; Kammerer U
    Anticancer Res; 2005; 25(3A):1747-53. PubMed ID: 16033094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MR imaging of uterine endometrial cancer.
    Tamai K; Koyama T; Saga T; Umeoka S; Mikami Y; Fujii S; Togashi K
    J Magn Reson Imaging; 2007 Sep; 26(3):682-7. PubMed ID: 17729360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New marker for blood vessels in human ovarian and endometrial cancers.
    Samoszuk M; Lin F; Rim P; Strathearn G
    Clin Cancer Res; 1996 Nov; 2(11):1867-71. PubMed ID: 9816142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor (AR) expression in normal and cancerous human endometrial tissues detected by RT-PCR and immunohistochemistry.
    Brys M; Semczuk A; Baranowski W; Jakowicki J; Krajewska WM
    Anticancer Res; 2002; 22(2A):1025-31. PubMed ID: 12014620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations.
    Semczuk A; Lorenc A; Putowski L; Futyma K; Bryk J; Miotla P; Bartnik E
    Oncol Rep; 2006 Nov; 16(5):1041-5. PubMed ID: 17016590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.